| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cardiac Surgical Procedures | 36 | 2020 | 1931 | 3.58 | Why? |
| Heart Defects, Congenital | 15 | 2020 | 933 | 2.80 | Why? |
| Cardiomyopathy, Hypertrophic | 11 | 2020 | 193 | 2.16 | Why? |
| Thoracic Surgery | 11 | 2020 | 623 | 2.15 | Why? |
| Tricuspid Valve | 7 | 2019 | 91 | 2.09 | Why? |
| Ebstein Anomaly | 6 | 2019 | 16 | 1.70 | Why? |
| Tricuspid Valve Insufficiency | 4 | 2019 | 94 | 1.70 | Why? |
| Heart Valve Prosthesis | 9 | 2019 | 533 | 1.57 | Why? |
| Mitral Valve | 10 | 2019 | 342 | 1.55 | Why? |
| Heart Valve Diseases | 5 | 2018 | 355 | 1.32 | Why? |
| Heart Valve Prosthesis Implantation | 9 | 2019 | 552 | 1.25 | Why? |
| Reoperation | 14 | 2019 | 544 | 1.14 | Why? |
| Thoracic Surgical Procedures | 2 | 2020 | 504 | 1.05 | Why? |
| Mitral Valve Insufficiency | 7 | 2019 | 302 | 1.04 | Why? |
| Aortic Valve | 5 | 2018 | 664 | 1.00 | Why? |
| Heart Septum | 6 | 2019 | 29 | 0.98 | Why? |
| Pacemaker, Artificial | 2 | 2017 | 431 | 0.97 | Why? |
| Heart Atria | 5 | 2019 | 267 | 0.89 | Why? |
| Robotic Surgical Procedures | 3 | 2017 | 787 | 0.87 | Why? |
| Robotics | 2 | 2017 | 528 | 0.86 | Why? |
| Aortic Aneurysm | 3 | 2018 | 121 | 0.78 | Why? |
| Transposition of Great Vessels | 2 | 2018 | 30 | 0.78 | Why? |
| Norwood Procedures | 1 | 2018 | 11 | 0.74 | Why? |
| Arterial Switch Operation | 1 | 2018 | 20 | 0.72 | Why? |
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 22 | 0.71 | Why? |
| Cardiovascular Surgical Procedures | 2 | 2020 | 281 | 0.68 | Why? |
| Aortic Valve Insufficiency | 1 | 2018 | 136 | 0.64 | Why? |
| Aneurysm | 1 | 2017 | 117 | 0.62 | Why? |
| Recovery of Function | 5 | 2020 | 2461 | 0.55 | Why? |
| Professionalism | 1 | 2017 | 171 | 0.55 | Why? |
| Cardiac Imaging Techniques | 1 | 2017 | 357 | 0.54 | Why? |
| Mitral Valve Annuloplasty | 3 | 2018 | 35 | 0.53 | Why? |
| Pulmonary Artery | 2 | 2018 | 803 | 0.52 | Why? |
| Postoperative Complications | 13 | 2019 | 5861 | 0.52 | Why? |
| Endocarditis, Bacterial | 1 | 2018 | 344 | 0.49 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.49 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.46 | Why? |
| Surgeons | 4 | 2020 | 2233 | 0.41 | Why? |
| Bioprosthesis | 4 | 2019 | 126 | 0.40 | Why? |
| Simulation Training | 1 | 2019 | 957 | 0.38 | Why? |
| Atrial Remodeling | 2 | 2019 | 31 | 0.38 | Why? |
| Prosthesis Failure | 4 | 2019 | 195 | 0.37 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.36 | Why? |
| Colitis, Ulcerative | 1 | 2018 | 1037 | 0.35 | Why? |
| Heart Aneurysm | 2 | 2018 | 46 | 0.34 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.33 | Why? |
| Minnesota | 9 | 2019 | 509 | 0.32 | Why? |
| Coronary Artery Bypass | 3 | 2017 | 629 | 0.32 | Why? |
| Calcinosis | 2 | 2018 | 240 | 0.29 | Why? |
| Pulmonary Valve | 2 | 2017 | 31 | 0.28 | Why? |
| Internship and Residency | 3 | 2020 | 4987 | 0.27 | Why? |
| Developing Countries | 2 | 2019 | 4283 | 0.26 | Why? |
| Treatment Outcome | 26 | 2019 | 51732 | 0.26 | Why? |
| Arrhythmias, Cardiac | 1 | 2017 | 2510 | 0.25 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.25 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.25 | Why? |
| Quality Improvement | 4 | 2019 | 2435 | 0.24 | Why? |
| Cardiac Catheterization | 3 | 2019 | 882 | 0.24 | Why? |
| Follow-Up Studies | 15 | 2019 | 17020 | 0.24 | Why? |
| Cardiopulmonary Bypass | 4 | 2016 | 158 | 0.23 | Why? |
| Mammary Arteries | 2 | 2018 | 31 | 0.23 | Why? |
| Ventricular Outflow Obstruction | 2 | 2018 | 23 | 0.23 | Why? |
| Societies, Medical | 6 | 2020 | 6907 | 0.22 | Why? |
| Mortality | 2 | 2019 | 7132 | 0.22 | Why? |
| Humans | 80 | 2020 | 930598 | 0.21 | Why? |
| Partnership Practice | 1 | 2019 | 12 | 0.20 | Why? |
| Formative Feedback | 1 | 2019 | 56 | 0.20 | Why? |
| Mitochondria, Heart | 1 | 2019 | 37 | 0.20 | Why? |
| Forkhead Box Protein O3 | 1 | 2019 | 30 | 0.20 | Why? |
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 839 | 0.20 | Why? |
| Survival Rate | 11 | 2019 | 9206 | 0.20 | Why? |
| Mitochondrial Dynamics | 1 | 2019 | 30 | 0.19 | Why? |
| Surgicenters | 1 | 2019 | 38 | 0.19 | Why? |
| Cardiology | 3 | 2020 | 2873 | 0.19 | Why? |
| Retrospective Studies | 30 | 2019 | 105322 | 0.19 | Why? |
| Heart Ventricles | 2 | 2018 | 1139 | 0.19 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 144 | 0.19 | Why? |
| Clinical Competence | 3 | 2019 | 3263 | 0.19 | Why? |
| Aorta | 2 | 2017 | 355 | 0.19 | Why? |
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2018 | 15 | 0.19 | Why? |
| Pulmonary Valve Stenosis | 1 | 2018 | 15 | 0.19 | Why? |
| Atrial Function, Left | 1 | 2019 | 82 | 0.19 | Why? |
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2018 | 11 | 0.19 | Why? |
| Courage | 1 | 2020 | 84 | 0.18 | Why? |
| Bundle-Branch Block | 1 | 2019 | 127 | 0.18 | Why? |
| Pericardiectomy | 1 | 2017 | 21 | 0.18 | Why? |
| Aortitis | 1 | 2018 | 39 | 0.18 | Why? |
| Duty to Warn | 1 | 2017 | 5 | 0.17 | Why? |
| Pericarditis, Constrictive | 1 | 2017 | 21 | 0.17 | Why? |
| Sternotomy | 1 | 2017 | 45 | 0.17 | Why? |
| Hemodynamics | 4 | 2019 | 1562 | 0.17 | Why? |
| Adrenal Cortex | 1 | 2016 | 22 | 0.17 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.16 | Why? |
| Postoperative Hemorrhage | 2 | 2017 | 183 | 0.16 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Reward | 1 | 2018 | 146 | 0.16 | Why? |
| Catheter Ablation | 2 | 2018 | 438 | 0.16 | Why? |
| Blood Loss, Surgical | 1 | 2018 | 211 | 0.16 | Why? |
| Proto-Oncogene Proteins | 1 | 2019 | 340 | 0.16 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2018 | 149 | 0.16 | Why? |
| Leadership | 5 | 2020 | 2241 | 0.16 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 396 | 0.16 | Why? |
| Death, Sudden | 1 | 2018 | 160 | 0.16 | Why? |
| Aged | 33 | 2020 | 215776 | 0.16 | Why? |
| Angiography | 1 | 2017 | 301 | 0.16 | Why? |
| Heart Conduction System | 1 | 2019 | 266 | 0.16 | Why? |
| Postoperative Care | 2 | 2018 | 755 | 0.15 | Why? |
| Pituitary-Adrenal System | 1 | 2016 | 135 | 0.15 | Why? |
| Conservative Treatment | 1 | 2019 | 349 | 0.15 | Why? |
| Hemostatics | 1 | 2017 | 142 | 0.15 | Why? |
| Education, Medical, Graduate | 2 | 2020 | 2082 | 0.15 | Why? |
| Echocardiography | 6 | 2019 | 3661 | 0.15 | Why? |
| Blood Coagulation Factors | 1 | 2017 | 223 | 0.15 | Why? |
| Female | 43 | 2020 | 380317 | 0.15 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.15 | Why? |
| Tachycardia | 1 | 2017 | 239 | 0.15 | Why? |
| Regenerative Medicine | 1 | 2017 | 161 | 0.14 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2016 | 187 | 0.14 | Why? |
| Syncope | 1 | 2018 | 238 | 0.14 | Why? |
| Middle Aged | 34 | 2020 | 270681 | 0.14 | Why? |
| Tachycardia, Ventricular | 1 | 2018 | 251 | 0.14 | Why? |
| Pediatrics | 3 | 2019 | 2969 | 0.14 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.14 | Why? |
| Time Factors | 11 | 2019 | 31397 | 0.14 | Why? |
| North America | 4 | 2020 | 1400 | 0.14 | Why? |
| Allografts | 1 | 2018 | 761 | 0.13 | Why? |
| Multivariate Analysis | 4 | 2018 | 5440 | 0.13 | Why? |
| Benchmarking | 1 | 2018 | 627 | 0.13 | Why? |
| Vasoplegia | 1 | 2013 | 27 | 0.13 | Why? |
| Prosthesis Design | 4 | 2019 | 594 | 0.13 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.13 | Why? |
| Survival Analysis | 6 | 2018 | 7592 | 0.13 | Why? |
| Male | 42 | 2020 | 367725 | 0.13 | Why? |
| Echocardiography, Transesophageal | 1 | 2017 | 447 | 0.13 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2017 | 365 | 0.13 | Why? |
| Quality Assurance, Health Care | 1 | 2019 | 596 | 0.13 | Why? |
| Hospital Administration | 1 | 2020 | 650 | 0.13 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.13 | Why? |
| Vasopressins | 1 | 2013 | 70 | 0.13 | Why? |
| Exercise Tolerance | 1 | 2019 | 634 | 0.13 | Why? |
| Calcium | 1 | 2018 | 708 | 0.13 | Why? |
| Child | 13 | 2020 | 70012 | 0.13 | Why? |
| Cardiology Service, Hospital | 1 | 2020 | 602 | 0.13 | Why? |
| Ventricular Function, Left | 2 | 2019 | 1555 | 0.12 | Why? |
| Databases, Factual | 5 | 2019 | 6248 | 0.12 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.12 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.12 | Why? |
| Health Care Surveys | 2 | 2020 | 2942 | 0.12 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.12 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.12 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.12 | Why? |
| Exercise Test | 1 | 2019 | 911 | 0.12 | Why? |
| Patient Safety | 4 | 2020 | 4885 | 0.12 | Why? |
| Myocardial Ischemia | 1 | 2019 | 781 | 0.12 | Why? |
| Virtual Reality | 1 | 2020 | 640 | 0.11 | Why? |
| Stents | 1 | 2019 | 916 | 0.11 | Why? |
| Safety Management | 1 | 2020 | 1093 | 0.11 | Why? |
| Surgical Wound Infection | 1 | 2017 | 501 | 0.11 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.11 | Why? |
| Elective Surgical Procedures | 2 | 2020 | 5338 | 0.11 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.11 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.10 | Why? |
| Tetralogy of Fallot | 1 | 2010 | 43 | 0.10 | Why? |
| Pandemics | 14 | 2020 | 389249 | 0.10 | Why? |
| Risk Assessment | 10 | 2020 | 25439 | 0.10 | Why? |
| Adult | 25 | 2020 | 244371 | 0.10 | Why? |
| Heart | 1 | 2019 | 1791 | 0.09 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.09 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.09 | Why? |
| Academic Medical Centers | 2 | 2018 | 3088 | 0.09 | Why? |
| Electrocardiography | 2 | 2019 | 3957 | 0.09 | Why? |
| General Surgery | 1 | 2020 | 1472 | 0.09 | Why? |
| Heart Neoplasms | 1 | 2008 | 77 | 0.09 | Why? |
| Hospital Mortality | 5 | 2018 | 22087 | 0.08 | Why? |
| Embolism | 1 | 2008 | 136 | 0.08 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.08 | Why? |
| Computed Tomography Angiography | 1 | 2017 | 2153 | 0.08 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.08 | Why? |
| Reconstructive Surgical Procedures | 1 | 2017 | 860 | 0.08 | Why? |
| Postoperative Period | 2 | 2019 | 651 | 0.08 | Why? |
| Patient Selection | 2 | 2018 | 4560 | 0.08 | Why? |
| Curriculum | 1 | 2020 | 3083 | 0.08 | Why? |
| Hydrocortisone | 1 | 2016 | 1790 | 0.08 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Aged, 80 and over | 11 | 2019 | 88759 | 0.07 | Why? |
| Sinus of Valsalva | 1 | 2004 | 12 | 0.07 | Why? |
| Propensity Score | 3 | 2018 | 2690 | 0.07 | Why? |
| Cohort Studies | 6 | 2018 | 36005 | 0.07 | Why? |
| Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.07 | Why? |
| Pulmonary Veno-Occlusive Disease | 1 | 2004 | 28 | 0.07 | Why? |
| Severity of Illness Index | 8 | 2019 | 48226 | 0.07 | Why? |
| Heart Septal Defects, Ventricular | 1 | 2004 | 33 | 0.07 | Why? |
| History, 20th Century | 3 | 2019 | 1282 | 0.07 | Why? |
| Triage | 2 | 2020 | 7151 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2019 | 9893 | 0.07 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.06 | Why? |
| Heart-Lung Machine | 2 | 2016 | 3 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Child, Preschool | 8 | 2019 | 36283 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.06 | Why? |
| Infant | 7 | 2019 | 30274 | 0.06 | Why? |
| Young Adult | 11 | 2020 | 93724 | 0.05 | Why? |
| United States | 5 | 2019 | 46150 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Thromboembolism | 2 | 2010 | 2101 | 0.05 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 49 | 0.05 | Why? |
| Ascites | 1 | 2019 | 65 | 0.05 | Why? |
| Heart Diseases | 1 | 2016 | 3503 | 0.05 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Preoperative Care | 2 | 2018 | 1515 | 0.04 | Why? |
| Preoperative Period | 1 | 2019 | 271 | 0.04 | Why? |
| Siberia | 1 | 2017 | 14 | 0.04 | Why? |
| Infant, Newborn | 5 | 2019 | 23105 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Transcortin | 1 | 2016 | 3 | 0.04 | Why? |
| Adrenal Cortex Function Tests | 1 | 2016 | 5 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Balloon Valvuloplasty | 1 | 2017 | 49 | 0.04 | Why? |
| Cosyntropin | 1 | 2016 | 9 | 0.04 | Why? |
| Contraindications | 1 | 2017 | 96 | 0.04 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2019 | 203 | 0.04 | Why? |
| Saphenous Vein | 1 | 2017 | 67 | 0.04 | Why? |
| Electrophysiological Phenomena | 1 | 2017 | 59 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Adrenocorticotropic Hormone | 1 | 2016 | 107 | 0.04 | Why? |
| Fontan Procedure | 1 | 2017 | 42 | 0.04 | Why? |
| Hospitals | 1 | 2016 | 11793 | 0.04 | Why? |
| Echocardiography, Doppler, Color | 1 | 2017 | 114 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Clinical Decision-Making | 2 | 2020 | 3755 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Adrenergic beta-Antagonists | 1 | 2019 | 465 | 0.04 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
| History, 19th Century | 1 | 2016 | 384 | 0.03 | Why? |
| Energy Metabolism | 1 | 2019 | 451 | 0.03 | Why? |
| Truth Disclosure | 1 | 2017 | 196 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.03 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.03 | Why? |
| Oximetry | 1 | 2019 | 658 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.03 | Why? |
| Health Services | 1 | 2020 | 765 | 0.03 | Why? |
| Occupational Health | 2 | 2020 | 3965 | 0.03 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.03 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.03 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.03 | Why? |
| Austria | 1 | 2017 | 1259 | 0.03 | Why? |
| Hospitals, University | 1 | 2005 | 4173 | 0.03 | Why? |
| Diffusion of Innovation | 1 | 2016 | 440 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2020 | 1216 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2019 | 639 | 0.03 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.03 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.03 | Why? |
| Hemostasis | 1 | 2017 | 811 | 0.03 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 5002 | 0.03 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.03 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.02 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.02 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.02 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.02 | Why? |
| Palliative Care | 1 | 2004 | 2665 | 0.02 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.02 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.02 | Why? |
| Intracranial Embolism | 1 | 2008 | 73 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| Coronary Angiography | 1 | 2017 | 2275 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Needs Assessment | 1 | 2017 | 2352 | 0.02 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Life Tables | 1 | 2004 | 46 | 0.02 | Why? |
| Dexamethasone | 1 | 2016 | 2055 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.02 | Why? |
| Canada | 1 | 2018 | 6018 | 0.02 | Why? |
| Marfan Syndrome | 1 | 2004 | 27 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.02 | Why? |
| Iran | 1 | 2017 | 5467 | 0.02 | Why? |
| Republic of Korea | 1 | 2017 | 5858 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.01 | Why? |
| Biomarkers | 2 | 2016 | 23361 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| Brazil | 1 | 2019 | 12582 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Cerebrovascular Disorders | 1 | 2008 | 1040 | 0.01 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Disease-Free Survival | 1 | 2004 | 1654 | 0.01 | Why? |
| Endocarditis | 1 | 2004 | 368 | 0.01 | Why? |
| Stroke | 2 | 2017 | 8839 | 0.01 | Why? |
| Age Distribution | 1 | 2008 | 3567 | 0.01 | Why? |
| Spain | 1 | 2017 | 15545 | 0.01 | Why? |
| Exercise | 1 | 2019 | 6771 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Oxygen | 1 | 2004 | 3715 | 0.01 | Why? |
| Pulmonary Embolism | 1 | 2008 | 4775 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2004 | 3361 | 0.01 | Why? |
| Anticoagulants | 1 | 2004 | 9563 | 0.00 | Why? |